Vanguard Capital Management »

Benitec Biopharma shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.9M 932k 10.65

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Capital Management

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Nantahala Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management
Millennium Management

View all funds holding Benitec Biopharma